Constanza Linossi
0000-0001-8749-5955
1 paper found
Refreshing results…
POSEIDON Trial Phase 1b Results: Safety, Efficacy and Circulating Tumor DNA Response of the Beta Isoform-Sparing PI3K Inhibitor Taselisib (GDC-0032) Combined with Tamoxifen in Hormone Receptor Positive Metastatic Breast Cancer Patients
Missing publications? Search for publications with a matching author name.